Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Barnes Group News

    35,91 $ -0,47% -0,17 $
    In : 33,645 € | 15:30:00 Uhr NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 861254
    ISIN: US0678061096
    US-Symbol: B
    Typ: Aktie

    Barnes Group News

    07.03.24 - PR Newswire
    BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference
    BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference PR Newswire
    08.02.24 - PR Newswire
    Flexxbotics and Zaptic Win Hexagon's Third 'Sixth Sense' Cohort of Advanced Manufacturing Startups
    Flexxbotics and Zaptic Win Hexagon's Third 'Sixth Sense' Cohort of Advanced Manufacturing Startups PR Newswire
    07.02.24 - PR Newswire
    Sectra continues its winning streak of global customer satisfaction with 5 Best in KLAS awards in 2024
    Sectra continues its winning streak of global customer satisfaction with 5 Best in KLAS awards in 2024 PR Newswire
    05.02.24 - PR Newswire
    ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023
    ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023 PR Newswire
    05.02.24 - PR Newswire
    ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023
    ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023 PR Newswire
    20.12.23 - PR Newswire
    Integrum establishes Center of Excellence in Ukraine
    Integrum establishes Center of Excellence in Ukraine PR Newswire
    10.11.23 - PR Newswire
    Clinical study of Integrum's OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense
    Clinical study of Integrum's OPRA™ Implant System on below-​knee amputations will include up to 30 patients and is fully funded by the Department of Defense PR Newswire
    09.11.23 - PR Newswire
    Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023
    Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 PR Newswire
    08.11.23 - PR Newswire
    Tele2 enables sustainable forestry with AirForestry and Nokia 5G Private Wireless
    Tele2 enables sustainable forestry with AirForestry and Nokia 5G Private Wireless PR Newswire
    27.10.23 - PR Newswire
    Integrum moves into Turkey
    Integrum moves into Turkey PR Newswire
    05.09.23 - PR Newswire
    Sectra's three-month interim report 2023/2024: Record-high order bookings
    Sectra's three-​month interim report 2023/2024: Record-​high order bookings PR Newswire
    23.08.23 - PR Newswire
    Invitation to presentation of Sectra's three-month interim report 2023/2024
    Invitation to presentation of Sectra's three-​month interim report 2023/2024 PR Newswire
    06.07.23 - PR Newswire
    Sectra publishes Annual Report and Sustainability Report for 2022/2023
    Sectra publishes Annual Report and Sustainability Report for 2022/2023 PR Newswire
    21.05.23 - PR Newswire
    Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic
    Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic PR Newswire
    16.05.23 - PR Newswire
    Societal value of lecanemab in Japan published in Neurology and Therapy
    Societal value of lecanemab in Japan published in Neurology and Therapy PR Newswire
    16.05.23 - PR Newswire
    Societal value of lecanemab in Japan published in Neurology and Therapy
    Societal value of lecanemab in Japan published in Neurology and Therapy PR Newswire
    12.05.23 - PR Newswire
    TSX Venture Exchange Stock Maintenance Bulletins
    TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire
    01.05.23 - PR Newswire
    Grupo Simec Files Its Form 20-F For The 2022 Financial Year
    Grupo Simec Files Its Form 20-F For The 2022 Financial Year PR Newswire
    03.04.23 - PR Newswire
    Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published
    Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published PR Newswire
    03.04.23 - PR Newswire
    Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published
    Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published PR Newswire

    Newssuche

    Videos

    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »